A recent survey indicates that a majority of Americans are supportive of using robotic and AI solutions to enhance cancer treatments.
Conducted by medical robotics company Quantum Surgical, the survey reveals significant insights into public attitudes toward cancer and emerging treatment technologies.
The study, carried out by YouGov, shows that 55% of American citizens are worried about the impact of cancer on younger generations. This concern is higher than in Germany, where only 37% share the same fear. Additionally, over half of Americans are worried about being diagnosed with cancer themselves, mirroring the concern of 54% of the French population. In stark contrast, only 47% of young Americans (aged 18 to 24) are concerned about future generations compared to 74% of young French individuals.
Confidence in Robotic Solutions
The survey highlights that 56% of Americans believe robotic or AI solutions could make cancer treatments more effective. This sentiment is echoed by 53% of the French but is less prevalent in Germany, where only 44% of respondents see robotics as a beneficial addition to cancer treatment. Among Americans, men are more optimistic about the potential of robotics, with 59% expressing confidence compared to 52% of women. A similar gender disparity exists in France, with 63% of men versus 44% of women supporting the effectiveness of robotics in cancer treatment.
Despite the positive outlook on robotic solutions, awareness of specific minimally invasive techniques such as percutaneous ablation remains low in the U.S. Only 7% of American citizens are familiar with this method, which significantly reduces recovery time. In comparison, 23% of the French population is aware of percutaneous ablation.
Industry Perspective
Bertin Nahum, President and Co-founder of Quantum Surgical, commented on the findings: “The WHO’s predictions suggest that cancer will unfortunately be a reality for many people. The fact that the majority of Americans believe that robotics and AI can make cancer treatments more effective is very encouraging. At Quantum Surgical, we have demonstrated with Epione® how technology can concretely assist practitioners in improving cancer treatment for patients.”
These insights underscore the importance of integrating advanced technologies into healthcare. As public confidence grows in the efficacy of robotic and AI solutions, the demand for skilled professionals in these areas is likely to increase. This shift not only represents a significant step forward in cancer treatment but also highlights the evolving landscape of healthcare jobs.
For more information on the survey and Quantum Surgical’s innovations, visit Quantum Surgical’s official website.